THE MEDICINES Classification Committee decision not to ease restrictions on low-dose cannabidiol, means businesses have no incentive to bring these products to market, a Hamilton-based pharmacist says.
The Medicines Classification Committee recommends not following Australia in easing restrictions on low-dose cannabidiol, but a Hamilton-based pharmacist says it’s a missed opportunity
The case of ADHD specialist GP Tony Hanne excited much comment last month, not least from pharmacy owner Ian McMichael who is concerned about the impact of bad prescribing on pharmacists and potential liability, writes Jonathan Chilton-Towle
Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes